Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Arif, Awan"'
Autor:
Karen Gambaro, Mélanie Groleau, Suzan McNamara, Arif Awan, Maged Salem, Mahmoud Abdelsalam, Eve St-Hilaire, François Vincent, Julie Carrier, Helen MacKay, Louise Provencher, Dominique Boudreau, Zineb Hamilou, Fred Saad, Cristiano Ferrario, Gerald Batist, Maud Marques
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 26 (2023)
There is an increasing demand for real-world data pertaining to the usage of cancer treatments, especially in settings where no standard treatment is specifically recommended. This study presents the first real-world analysis of third-line treatment
Externí odkaz:
https://doaj.org/article/feab0871603e4619976a4a6c0af8c91a
Autor:
Mark Clemons, Dean Fergusson, Anil A. Joy, Kednapa Thavorn, Judith Meza-Junco, Julie Price Hiller, John Mackey, Terry Ng, Xiaofu Zhu, Mohammed F.K. Ibrahim, Marta Sienkiewicz, Deanna Saunders, Lisa Vandermeer, Gregory Pond, Bassam Basulaiman, Arif Awan, Lacey Pitre, Nancy A. Nixon, Brian Hutton, John F. Hilton
Publikováno v:
Breast, Vol 58, Iss , Pp 42-49 (2021)
Background: Primary febrile neutropenia (FN) prophylaxis with ciprofloxacin or granulocyte-colony stimulating factors (G-CSF) is recommended with docetaxel-cyclophosphamide (TC) chemotherapy for early-stage breast cancer (EBC). A pragmatic randomised
Externí odkaz:
https://doaj.org/article/7167d8bf23184b0bbe70775be20aa64b
Autor:
Arif Awan, Bassam Basulaiman, Carol Stober, Mark Clemons, Dean Fergusson, John Hilton, Waleed Al Ghareeb, Rachel Goodwin, Mohammed Ibrahim, Brian Hutton, Lisa Vandermeer, Ranjeeta Mallick, Michael M. Vickers
Publikováno v:
Health Science Reports, Vol 4, Iss 4, Pp n/a-n/a (2021)
Abstract Background and Aims Optimal management of cancer treatment‐induced hypomagnesemia (hMg) is not known. We assessed the feasibility of using a novel pragmatic clinical trials model to compare two commonly used oral Mg replacement strategies.
Externí odkaz:
https://doaj.org/article/e7ab467f882149c78edb5d5ab9e43411
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe use of Next-Generation Sequencing (NGS) has recently allowed significant improvements in cancer treatment. Foundation Medicine® (FM) provides a genomic profiling test based on NGS for a variety of cancers. However, it is unclear if the
Externí odkaz:
https://doaj.org/article/64aecf91b52e4488bf5f05b071c5901b
Autor:
David W. Cescon, John Hilton, Philippe Bedard, Phillip Blanchette, Rossanna C. Pezo, Ayesha Bashir, Vikaash Kumar, Terry L. Ng, Arif Awan, Anthony Lott, Jacques Antoun Raphael, Linda Hagerman, Mark Bray, Lindsay Muyot, Jesus Fuentes Antras, Lesley Seymour, Dongsheng Tu, Pierre-Olivier Gaudreau, Moira Rushton
Publikováno v:
Cancer Research. 83:P3-07
Background: CFI-400945 is a selective oral inhibitor of Polo-like Kinase 4 (PLK4), a controller of centriole duplication and mitotic progression identified by functional screening of genomically unstable breast cancer (BC). IND.237 (NCT01954316) is a
Autor:
Philippe Bedard, Mihaela Mates, John Hilton, Nathalie Levasseur, Arif Awan, Amirrtha Srikanthan, David W. Cescon, Karen Gelmon, Andrew Robinson, Nancy Drummond-Ivars, Irene Li, Laleh Rastgou, Jackie Edwards, Linda Hagerman, Siwei Zhang, Mark Bray, Lesley Seymour, Moira Rushton, Pierre-Olivier Gaudreau
Publikováno v:
Cancer Research. 83:P3-07
CCTG IND.236: A Phase 1b trial of combined CFI-402257 and weekly paclitaxel in patients with HER2-negative (HER2-) advanced breast cancer (aBC) Philippe L. Bedard, Mihaela Mates, John Hilton, Nathalie Levasseur, Arif Awan, Amirrtha Srikanthan, David
Autor:
John Hilton, David W. Cescon, Andrew Robinson, Sukhbinder Dhesy-Thind, Sara Taylor, Arif Awan, Terry L. Ng, Moira Rushton, Marie-France Savard, Lindsay Muyot, Marie Claude Reeves, Linda Hagerman, Hongbo Lui, Mark Bray, Dongsheng Tu, Lesley Seymour, Pierre-Olivier Gaudreau
Publikováno v:
Cancer Research. 83:P3-07
CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC) John Hilton, David W. Cescon, Andrew Robinson, Sukhbinder Dhesy-Thind, Sara Kristina Taylor, Arif Awan, Terry Ng, Moir
Autor:
Sharon McGee, Mashari AlZahrani, Carol Stober, Terry L. Ng, Katherine Cole, Gail Larocque, Arif Awan, Sandeep Sehdev, John Hilton, Lisa Vandermeer, Brian Hutton, Gregory Pond, Deanna Saunders, Mark Clemons
Publikováno v:
Journal of Bone Oncology, Vol 27, Iss , Pp 100351- (2021)
Background: Despite the increasing use of adjuvant bisphosphonates for early stage breast cancer (EBC), little is known about the patient experience with such treatments. A patient survey was performed to identify current prescribing practices, perce
Externí odkaz:
https://doaj.org/article/f1411dede35d4fa1a6439a23035a2735
Autor:
Arif Awan, Terry Ng, Henry Conter, William Raskin, Carol Stober, Demetrios Simos, Greg Pond, Sukhbinder Dhesy-Thind, Mihaela Mates, Vikaash Kumar, Dean Fergusson, Brian Hutton, Deanna Saunders, Lisa Vandermeer, Mark Clemons
Publikováno v:
Journal of Bone Oncology, Vol 26, Iss , Pp 100343- (2021)
Background: Adjuvant zoledronate is widely used in patients with early stage breast cancer (EBC), but its optimal duration and dosing interval is still unknown. While a single-dose of zoledronate can improve bone density for many years, a proper eval
Externí odkaz:
https://doaj.org/article/9cbee11243204b0a8c3c062e7a1485a9
Autor:
Angel Arnaout, Susan Robertson, Kianoosh Keyhanian, Arif Awan, Gregory Pond, John Bartlett, Megan Hopkins, Linda Liao, Vida Talebian, Lazlo Radvyani, Lewis Bender, Ian Walters, Vanessa Lopez Ozuna, Melanie Spears
Publikováno v:
Regular and Young Investigator Award Abstracts.